'Operation Stork Speed' Prepares to Overhaul Baby Formula Guidelines
via HealthDayFRIDAY, Feb. 20, 2026 — During their first six months of life, many infants get some or all of their calories from formula, but federal rules governing what goes into those bottles haven't been updated in decades.
That may soon change under a federal initiative dubbed Operation Stork Speed that was launched last March to bring U.S. infant formula standards into the modern era.
"The nutrition of every bottle-fed infant in America is at stake," Tom Brenna told The Wall Street Journal. He's a professor of pediatrics at the University of Texas at Austin who was part of a federal panel of nutritionists and scientists last summer.
Most guidelines around infant formula date back to 1985, with only some minor amendments thereafter.
This spring, the U.S. Food and Drug Administration (FDA) plans to release a report that reviews contaminants in formula and required ingredients.
Unlike the European Union and Australia, the United States has not set maximum allowable levels for any environmental contaminants in baby formula. This includes, for example, lead, tin, cadmium, arsenic and others.
Recent reports have shown that nearly half of the powdered formulas on the U.S. market contain detectable levels of lead or arsenic.
While these metals are often trace amounts found naturally in the environment, the Trump administration is looking to set much stricter limits.
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has said the regulations are based on old science that fails to account for modern health concerns.
"It’s archaic science," he said recently.
However, some of the more controversial goals championed by the Make America Healthy Again movement — such as removing seed oils — may have hit a wall of scientific and industrial reality, according to The Wall Street Journal.
While critics argue seed oils are "unnatural," manufacturers and pediatricians point out that these oils provide linoleic acid, an essential fat that is also found in breast milk. Swapping them out without a clear, safe alternative could disrupt the delicate balance of infant nutrition, they warn.
A string of high-profile formula recalls has fueled the push for change. Recently, major infant formula brands have had issues with bacterial contamination, reminding parents and policymakers that the supply chain remains fragile.
The results of the FDA review are expected to be unveiled in April.
The report will likely include a nutrient review of ingredients, such as fatty acids, as well as new safety protocols to minimize contaminants and prevent the type of outbreaks that have caused recent formula shortages and recalls in the U.S. and abroad.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-02-21 15:58
Read more
- Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
- Satisfaction With Semaglutide Driven by Effective Weight Loss
- Exercise Can Reduce Depression, Anxiety Symptoms
- Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA PF’3944 Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial
- Migraine Common in Women With Macromastia, Headache
- Keytruda and Keytruda Qlex, Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions